No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
No Data
Clinical Trial Investigative Site Network Market Analysis Report 2025-2030, Featuring ICON, IQVIA, WCG Clinical, ClinChoice, SGS, FOMAT Medical Research, SMO-Pharmina, Xylem Research and More
WCG Clinical Announces Relaunch of FDAnews as the Premier Source for Drug and Device Insights
BRIEF-WCG Appoints Sam Srivastava as Chief Executive Officer
WCG Clinical Files to Withdraw IPO
BRIEF-WCG Clinical Inc Files To Withdraw IPO Plans
GIC-backed clinical trial firm WCG withdraws IPO plans
Unlock the Full List